Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Donald S. Robinson, MD
JCP
Original Research
A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder
April 15, 2011
Arif Khan
,
Andrew J. Cutler
,
Daniel K. Kajdasz
, et al
JCP
Original Research
Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
March 10, 2009
Karl Rickels
,
Maria Athanasiou
,
Donald S. Robinson
, et al
JCP
Original Research
Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials
December 14, 2007
Arif Khan
,
Kelly Schwartz
,
Chelsea Stern
, et al
JCP
Original Research
Selegiline Transdermal System for the Treatment of Major Depressive Disorder: An 8-Week, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Trial
September 15, 2006
Alan D. Feiger
,
Karl Rickels
,
Moira A. Rynn
, et al
